We speak to Fabrice André about the SOLAR-1 trial and its impact on the care of patients with hormone receptor-positive, HER2-negative advanced breast cancer (5:19).
24-10-2018 | Breast cancer | ESMO 2018 | Video
24-10-2018 | Breast cancer | ESMO 2018 | Video
We speak to Fabrice André about the SOLAR-1 trial and its impact on the care of patients with hormone receptor-positive, HER2-negative advanced breast cancer (5:19).